Evidence map›Paper›PMID 20662064›Full record

ArticleArthritis and rheumatism2010

C5a receptor enables participation of mast cells in immune complex arthritis independently of Fcγ receptor modulation.

Peter A Nigrovic, Odile Malbec, Bao Lu, Maciej M Markiewski, Chris Kepley, Norma Gerard, Craig Gerard, Marc Daëron, David M Lee

Open access · greenAbstract read
In one paragraph

Article in Arthritis and rheumatism, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Novel Strategies to Target Mast Cells in Disease.Journal of innate immunity · 2021
    Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Evaluation of synovial mast cell functions in autoimmune arthritis.Methods in molecular biology (Clifton, N.J.) · 2015
    Article
  12. Article
  13. Neutrophils orchestrate their own recruitment in murine arthritis through C5aR and FcγR signaling.Proceedings of the National Academy of Sciences of the United States of America · 2012
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 2 countries.

Peter A NigrovicBrigham and Women's Hospital and Children's Hospital Boston, Boston, Massachusetts, USA.
Odile Malbec
Bao Lu
Maciej M Markiewski
Chris Kepley
Norma Gerard
Craig Gerard
Marc Daëron
David M Lee
Boston Children's Museum · USInserm · FRBrigham and Women's Hospital · USHarvard University · USLuna Innovations (United States) · USUniversity of Pennsylvania · US

Funding

Synovial Mast Cells in Inflammatory ArthritisR01AI059746 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI STEVENS, RICHARD L · 2004 to 2013
$3.3M
Using Nanomaterials to Inhibit Mast Cell/Basophil-Associated DiseaseR01GM083274 · NIGMS · LUNA INNOVATIONS, INC. · PI KEPLEY, CHRIS L · 2008 to 2012
$1.5M
C5a receptor on mast cells in inflammatory arthritisK08AR051321 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI NIGROVIC, PETER A · 2006 to 2010
$643k
Prevention of Allergic Disease Using NanomaterialsR21ES015696 · NIEHS · LUNA INNOVATIONS, INC. · PI KEPLEY, CHRIS L · 2009 to 2010
$556k
Generation of antigen specific regulatory T cellsR21AI059745 · NIAID · UNIVERSITY OF ILLINOIS AT CHICAGO · PI VASU, CHENTHAMARAKSHAN · 2004 to 2005
$426k
NIAID NIH HHS R01-AI-059745NIAID NIH HHS R01 AI059746NIAID NIH HHS R21 AI059745NIAMS NIH HHS K08 AR051321NIAMS NIH HHS K08-AR-051321NIEHS NIH HHS R21 ES015696NIEHS NIH HHS R21-ES-015696NIGMS NIH HHS R01 GM083274NIGMS NIH HHS R01-GM-083274-01
6 · The paper itself

Abstract

objectiveMast cells are tissue-resident immune sentinels that are implicated in the pathogenesis of inflammatory joint disease. The aim of this study was to test our hypothesis that complement fragments could be key activators of synovial mast cells in autoimmune arthritis.

methodsIn vivo studies used the murine K/BxN arthritis model, a distal symmetric polyarthritis mediated by IgG immune complexes. Expression of C5aR on synovial mast cells was determined by immunohistochemical and functional studies. C5aR(-/-) and control mast cells were engrafted into mast cell-deficient WBB6 F1-Kit(w) /Kit(W-v) (W/Wv) mice to examine the requirement for this receptor in arthritis. C5aR-dependent activation of mast cells was investigated in C5aR(-/-) animals and in murine and human mast cell cultures.

resultsMurine synovial mast cells express functional C5aR. Unlike their wild-type counterparts, C5aR(-/-) mast cells adoptively transferred into W/Wv mice were not competent to restore arthritis, despite equivalent synovial engraftment. Activation of C5aR(-/-) mast cells by K/BxN serum in vivo remained intact, indicating that C5aR is dispensable for normal IgG-mediated triggering. Consistent with this result, cultured mast cells treated with C5a failed to modulate the expression of Fcγ receptors (FcγR) or to otherwise alter the activation threshold. In human mast cells, C5a promoted the production of the neutrophil chemotaxin interleukin-8, and recruitment of neutrophils at 24 hours after serum administration was impaired in C5aR(-/-) mice, suggesting that enhanced neutrophil chemoattractant production underlies the requirement for C5aR on mast cells in arthritis.

conclusionStimulation via C5aR is required to unleash the proinflammatory activity of synovial mast cells in immune complex arthritis, albeit via a mechanism that is distinct from C5a-modulated expression of FcγR.

Indexed as

AnimalsAntigen-Antibody ComplexArthritis, ExperimentalCells, CulturedMast CellsMiceNeutrophil InfiltrationReceptor, Anaphylatoxin C5aReceptors, IgGReverse Transcriptase Polymerase Chain ReactionAntigen-Antibody ComplexReceptor, Anaphylatoxin C5aReceptors, IgG

Identifiers

PMID20662064
PMCPMC2970731
OpenAlexW2100706530

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.